Companies: 10,795·Total market cap: $144.5T
Nunzia Pharmaceutical Company

Nunzia Pharmaceutical Company

NUNZOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$43451
P/E Ratio
52W High$0.003
52W Low$0.0001

Nunzia Pharmaceutical Company (NUNZ) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · NUNZ · as of Jun 9, 2026

Activity summary

Buy transactions

8

P-Purchase only

Sell transactions

1

12 Months

Buy/Sell ratio

8.00

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 89%Active transactions only · RSU vesting excluded11% Sell ↓

Nunzia Pharmaceutical Company insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

NUNZ insider buying and selling by quarter

NUNZ insider selling · NUNZ insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
56.9M28.5M0
2005 Q4
2006 Q1
2006 Q2
2006 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

NUNZ executive sell shares · NUNZ board member insider trading · NUNZ insider trading SEC filing

Showing 14 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

HENRY G DAVID

Director

Purchase

Date

Oct 30

Shares

25,000

Price

$0.02

Value

$500

View Form 4 on SEC.gov

HENRY G DAVID

Director

Purchase

Date

Oct 18

Shares

100,000

Price

$0.02

Value

$2K

View Form 4 on SEC.gov

HENRY G DAVID

Director

Purchase

Date

Jun 14

Shares

10,000

Price

$0.02

Value

$180

View Form 4 on SEC.gov

HENRY G DAVID

Director

Purchase

Date

May 3

Shares

3,913

Price

$0.04

Value

$157

View Form 4 on SEC.gov

HENRY G DAVID

Director

Purchase

Date

May 2

Shares

55,000

Price

$0.42

Value

$23K

View Form 4 on SEC.gov

HENRY G DAVID

Director

Purchase

Date

Apr 28

Shares

110,000

Price

$0.04

Value

$5K

View Form 4 on SEC.gov

HENRY G DAVID

Director

Sale

Date

Jan 30

Shares

5,386,667

Price

Value

View Form 4 on SEC.gov

HENRY G DAVID

Director

Award

Date

Dec 16

Shares

2,500,000

Price

$0.02

Value

$50K

View Form 4 on SEC.gov

HENRY G DAVID

Director

Gift

Date

Dec 16

Shares

1,250,000

Price

Value

View Form 4 on SEC.gov

HENRY G DAVID

Director

Gift

Date

Dec 16

Shares

1,250,000

Price

Value

View Form 4 on SEC.gov

HENRY G DAVID

Director

Purchase

Date

Dec 29

Shares

34,698

Price

$0.04

Value

$1K

View Form 4 on SEC.gov

Kron Roger Alan

COO · Director

Award

Date

Dec 29

Shares

500,000

Price

$0.02

Value

$10K

View Form 4 on SEC.gov

Kron Roger Alan

COO · Director

Purchase

Date

Aug 8

Shares

245,466

Price

$0.06

Value

$15K

View Form 4 on SEC.gov

Hitz Kingman L

CFO

Purchase

Date

Aug 8

Shares

245,466

Price

$0.06

Value

$15K

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About NUNZ insider trading

NUNZ insider trades

Nunzia Pharmaceutical Company (NUNZ) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including NUNZ. Over the past 12 months, 0 insiders have filed transactions with the SEC. NUNZ insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Nunzia Pharmaceutical Company's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

NUNZ insider trading · 5 questions

The insiders of Nunzia Pharmaceutical Company (NUNZ) include executives and directors such as NUNZ, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

NUNZ board member insider tradingwho are NUNZ insidersNUNZ insider rosterNunzia Pharmaceutical Company executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026